Mirna Therapeutics is a biotech company based in Austin, Texas. They specialize in the development of products that use unique microRNA ingredients in the treatment of cancer. What microRNA therapeutics do is combine beneficial medicines with natural organic compounds. These cooperate easily with the human bodies’ internal systems so that there is a higher absorption rate and less risk of rejection or damage by the human bodies internal systems. Essentially the drugs produced by Mirna supplement the patients immune system.
This is a drastic change from many prexisting cancer treatments, which introduce artificial chemicals into the body in large amounts. These can be effective in destroying cancer cells but also damage the bodie and can result in severe side effects.
Recently Dr. Clay Siegall was granted a seat on Mirna’s board of directors. Siegall is a respected researcher and developer who helped cofound the company Seattle Genetics. Seatlle Genetics is current a leading producer of antibody based pharmecuticals and any partnership between it and Mirna is sure to lead to positive results.
Dr. Siegall has had a long and successful career in the field of medical research. He graduated from George Washington University with a Ph.D. in Genetics and also holds a B.S. from the University of Maryland in the field of Zoology. He spent a total of six years working at the National Cancer Institute and the next 3 employed by the National Institutes of Health.
Representatives from Mirna said that they are happy to have his experience and insight on hand.